Management of Local-Regional Anal Cancer Recurrence

Shilpa S. Murthy; Elin R. Sigurdson

doi:10.1007/978-3-030-20253-8_6

Management of Local-Regional Anal Cancer Recurrence

Shilpa S. Murthy, Elin R. Sigurdson

Temple University

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Anal cancer, a rare gastrointestinal disease, accounts for 1–2.5% of gastrointestinal cancers. Primary treatment is chemoradiation. Ten to 30% of patients experience local relapse, and salvage surgery is a second line of treatment for these patients. Wide local excision, abdominoperineal resection, pelvic exenteration with or without sacrectomy, and inguinal node dissection are all surgical options. In this chapter, we review the management and treatment options for patients who are initially treated with chemoradiation and experience local-regional recurrence of the disease.

Original language	English
Title of host publication	Anal Cancer
Subtitle of host publication	A Comprehensive Guide
Publisher	Springer Science+Business Media
Pages	85-94
Number of pages	10
ISBN (Electronic)	9783030202538
ISBN (Print)	9783030202521
DOIs	https://doi.org/10.1007/978-3-030-20253-8_6
State	Published - Jan 1 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-030-20253-8_6

Cite this

@inbook{5c85800f2a374f4190bb5d9ebbe3aadb,

title = "Management of Local-Regional Anal Cancer Recurrence",

abstract = "Anal cancer, a rare gastrointestinal disease, accounts for 1–2.5% of gastrointestinal cancers. Primary treatment is chemoradiation. Ten to 30% of patients experience local relapse, and salvage surgery is a second line of treatment for these patients. Wide local excision, abdominoperineal resection, pelvic exenteration with or without sacrectomy, and inguinal node dissection are all surgical options. In this chapter, we review the management and treatment options for patients who are initially treated with chemoradiation and experience local-regional recurrence of the disease.",

author = "Murthy, {Shilpa S.} and Sigurdson, {Elin R.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2019.",

year = "2019",

month = jan,

day = "1",

doi = "10.1007/978-3-030-20253-8_6",

language = "English",

isbn = "9783030202521",

pages = "85--94",

booktitle = "Anal Cancer",

publisher = "Springer Science+Business Media",

}

TY - CHAP

T1 - Management of Local-Regional Anal Cancer Recurrence

AU - Murthy, Shilpa S.

AU - Sigurdson, Elin R.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Anal cancer, a rare gastrointestinal disease, accounts for 1–2.5% of gastrointestinal cancers. Primary treatment is chemoradiation. Ten to 30% of patients experience local relapse, and salvage surgery is a second line of treatment for these patients. Wide local excision, abdominoperineal resection, pelvic exenteration with or without sacrectomy, and inguinal node dissection are all surgical options. In this chapter, we review the management and treatment options for patients who are initially treated with chemoradiation and experience local-regional recurrence of the disease.

AB - Anal cancer, a rare gastrointestinal disease, accounts for 1–2.5% of gastrointestinal cancers. Primary treatment is chemoradiation. Ten to 30% of patients experience local relapse, and salvage surgery is a second line of treatment for these patients. Wide local excision, abdominoperineal resection, pelvic exenteration with or without sacrectomy, and inguinal node dissection are all surgical options. In this chapter, we review the management and treatment options for patients who are initially treated with chemoradiation and experience local-regional recurrence of the disease.

UR - http://www.scopus.com/inward/record.url?scp=105007782464&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-20253-8_6

DO - 10.1007/978-3-030-20253-8_6

M3 - Chapter

AN - SCOPUS:105007782464

SN - 9783030202521

SP - 85

EP - 94

BT - Anal Cancer

PB - Springer Science+Business Media

ER -

Management of Local-Regional Anal Cancer Recurrence

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this